Artificial Intelligence Technologies Market 2019| Intel, Nvidia, Google, IBM, Microsoft, General Vision, Enlitic, Next IT, Welltok, Icarbonx, Koninklijke Philips

Albany, NY, 21st January : Recent research and the current scenario as well as future market potential of "Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018" globally.

GBI Research’s latest report: “Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views From Industry Survey 2018” considers the current and future impact of artificial intelligence (AI) technologies within the pharmaceutical and healthcare sectors.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1798330

AI is defined as the theoretical and practical application of computer systems able to perform tasks usually requiring human intelligence such as visual perception, learning, decision making and translation between languages. The healthcare and pharmaceutical sectors are among the pioneers of AI adoption and development within industry as a whole.

This is driven by the need to reduce research and development (R&D) costs, and to meet consumer demand for effective medical interventions at a reasonable price. This report features an overview of AI technologies, with a focus on how these technologies will impact the pharmaceutical and healthcare industry. It examines factors driving the use of AI in R&D, and provides detailed examples of how different platforms and services can provide direct benefits to both the healthcare industries and consumers using them.

GBI Research conducted a targeted industry survey of experts and key opinion leaders in the AI field to gather insight and opinions on the current trends and future commercial prospects of the use of AI within the healthcare and pharmaceutical sectors. The survey explored a wide range of strategic topics in the field, including key market drivers and restraints, and the most common areas where the AI technologies are being applied within the pharmaceutical pipeline development chain, prospects for future investments in AI, important factors to consider when implementing AI in industry, and other important areas for current and future investors in AI.

The report also provides an analysis of the main challenges surrounding the adoption of AI technologies within the healthcare and pharmaceutical industries. AI developers and investors in the market will still need to address significant barriers to achieve higher adoption rates in the market. Mitigating risks and concerns regarding data security and privacy will be crucial.

Other important restraints identified in this report include the currently unclear regulatory and legal frameworks surrounding AI, and the shortage of skilled IT professional in the healthcare industry. Despite the aforementioned barriers to the further expansion of the AI market, growing investment in AI and digital pharmaceutical developments represent encouraging trends.

View Complete TOC with tables & Figures @ https://www.researchmoz.us/artificial-intelligence-technologies-market-prospects-featuring-expert-panel-views-from-industry-survey-2018-report.html/toc

Scope

How prevalent is the usage of AI technologies within the healthcare and pharmaceutical sectors and how will this change in the coming years?
What are the most important drivers and restraints of AI adoption within healthcare and pharmaceuticals?
What are the key stakeholders in the funding and provision of AI technologies within healthcare and pharmaceuticals?
How will different sectors, such as clinical trials, diagnostics and epidemiological forecasting be impacted by AI technologies?

Reasons to buy

Develop a comprehensive understanding of AI technologies and their applications within the healthcare and pharmaceutical sectors
Gain insight into the key players within the industry, including multi-national technology firms and AI start-up firms, with case studies and company profiles
Analyze trends within the AI strategic consolidations landscape
Gain insights from industry experts on the current status and future prospects for AI within healthcare and pharmaceuticals (GBI Research’s survey comprises responses from 105 organizations)

Table of Contents

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 7

2 Overview of Artificial Intelligence Technologies 9
2.1 Current and Future Value of Global Artificial Intelligence Market 9
2.2 What is Artificial Intelligence? 9
2.2.1 Machine Learning 10
2.2.2 Algorithms 13
2.2.3 Data Sharing Platforms 13
2.2.4 Future Considerations 14

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1798330

3 Artificial Intelligence in the Healthcare and Pharmaceutical Industries 15
3.1 Overview of Artificial Intelligence in the Pharmaceutical and Healthcare Industries 15
3.2 Services Benefitting From Artificial Intelligence Technologies within the Healthcare and Pharmamceutical Sectors 15
3.3 Key Objectives of Artificial Intelligence Technologies within Healthcare and Pharmaceuticals? 16
3.4 Key Stakeholders in the Funding and Provision of Artificial Intelligence Technologies 17
3.4.1 Payers 18
3.4.2 Financial intermediaries 18

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket Ghumare,
ResearchMoz,
90 State Street, Albany NY, United States,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Follow me on : https://marketinfo247.wordpress.com/

This release was published on openPR.